TOKYO, Nov. 7, 2024 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY…
Novel H2CasMab-2 Antigen Binding Domain Shown to Preferentially Target HER2 Expressed on Tumor Cells in Preclinical Studies Initial Low-Dose Cohort…
MILAN, Nov. 6, 2024 /PRNewswire/ -- As the world's leading electric two-wheeler brand, TAILG launched its flagship new product S96MAX at…
TOKYO, Nov. 7, 2024 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY…
TOKYO, Nov. 7, 2024 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY…
MILAN, Nov. 6, 2024 /PRNewswire/ -- As the world's leading electric two-wheeler brand, TAILG launched its flagship new product S96MAX at…
TOKYO, Nov. 7, 2024 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY…
MILAN, Nov. 6, 2024 /PRNewswire/ -- As the world's leading electric two-wheeler brand, TAILG launched its flagship new product S96MAX at…
TOKYO, Nov. 7, 2024 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY…
MILAN, Nov. 6, 2024 /PRNewswire/ -- As the world's leading electric two-wheeler brand, TAILG launched its flagship new product S96MAX at…